Opendata, web and dolomites

ARM-B

The ARM-B skin-allergy diagnostics patch is a compact, easy to apply, low-cost allergy testing product.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ARM-B project word cloud

Explore the words cloud of the ARM-B project. It provides you a very rough idea of what is the project "ARM-B" about.

engineered    draws    setting    specialist    allogen    pain    depths    ultra    therapist    shaped    ensures    provides    market    reactions    invasiveness    nausea    intrusive    allergen    patient    allergic    severity    penetrating    acquires    applicable    picomole    consequence    outcomes    pricks    patch    markets    panel    home    microgel    interpreted    epidermis    raining    accredited    skin    advantages    allergy    diagnostics    consultation    offers    stick    degree    minutes    innovation    nl    uses    risk    oriented    healthcare    disc    reliability    malaise    segments    clinical    minimising    reaction    collated    company    mark    patients    impedance    biosensors    register    viz    innovating    purified    arm    data    prevalent    mm    tine    practitioners    millimetre    quantitative    biotech    simplicity    microelectrode    alternative    extends    prick    biosensor    microns    alike    vivo    panels    solution    clinics    adverse    individual    structure    self    dataset    electrical    few    free    microarray    hundred    device    pen    sensors    allergens   

Project "ARM-B" data sheet

The following table provides information about the project.

Coordinator
ALLOGEN BIOTECH LIMITED 

Organization address
address: 12 SEAFIELD ROAD CLONTARF
city: DUBLIN
postcode: D03YT25
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Ireland [IE]
 Project website http://www.allogenbiotech.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-06-01   to  2018-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ALLOGEN BIOTECH LIMITED IE (DUBLIN) coordinator 50˙000.00

Map

 Project objective

Allogen Biotech is innovating the ARM-B allergy diagnostics patch technology for use in the healthcare sector and home-test markets. The company’s advanced biosensor concept draws on the simplicity and reliability of traditional skin-prick procedures, yet provides improved clinical outcomes and patient experience. The Allogen innovation is engineered as 50 mm stick-on disc-shaped patch, composed of a microarray device, which identify panels of allergic reactions. Each type of allergic response is interpreted as electrical impedance changes at individual biosensors. The allergy specialist acquires the test results in 5 minutes on a wide panel of common or specific allergens. The sensors register the degree of severity of an allergic reaction and may provide further information on specific testing. The ARM-B system offers unique advantages for the allergy therapist and patients alike. The patch device is non-intrusive – no need to pen-mark or prick large areas of skin: ARM-B microarray extends only 30 mm. The tine-microelectrode structure of the biosensor component ensures ultra-low invasiveness, penetrating only a few hundred microns of epidermis, not millimetre skin-prick depths. Therefore the ARM-B test offers a pain free consultation. The in vivo patch uses only picomole/nL, of a purified allergen microgel, minimising the risk of adverse side effects prevalent with skin-pricks – viz. nausea, raining, malaise. The device offers a large allergy dataset, a consequence of the microarray concept. The sensors are quantitative, so data on degree of allergic response or severity is collated. The solution to skin-oriented allergy diagnostics is applicable to several alternative market segments, not only accredited clinics and general practice with specialist allergy practitioners, but also in the self-test or home-use setting. ARM-B is a high value, low-cost solution for allergy diagnostics.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ARM-B" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ARM-B" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Dyme (2019)

Dyme gives its users complete control over their financial situation. The Dyme application provides insight into users’ spending and subscriptions, and lets users cancel, negotiate, or switch any cont

Read More  

DeltaQon (2019)

IOT and cloud computing for online medical analysis service platform

Read More  

HUD (2018)

COMMERCIALIZING THE FIRST HEAD-UP-DISPLAY FOR OFF-HIGHWAY VEHICLES

Read More